New research in mice may explain why aspirin seems to lower the risk of people's cancers spreading out of control.
The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.
Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells ...
9h
News Medical on MSNDiabetes drug could help cancer patients make better recoveryA common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...
Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...
Scientists have described the “Eureka moment” when they discovered how aspirin may prevent some cancers from spreading. Their ...
Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the immune system. The scientists say that discovering the mechanism will support ...
ITM, a pioneer in radiopharmaceuticals, said it will submit its first drug for approval after reporting the therapy halted ...
The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking ...
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results